维普中文期刊产品整合服务
15篇 您的检索式:作者名="Shyangdan"
    题名 作者 年代 出处 被引量
1Insulin sensitisers in the treatment of non-alcoholic fatty liver disease : a systematic review 显示文摘Shyangdan D Clar C Ghouri N 2011HeahhTechnol Assess2011,15,38:1
2A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression 显示文摘Sutcliffe P Connock M Shyangdan D 2013Health technol Assess2013,17,42:1
3Liraglutide for the treatment of type 2 diabetes显示文摘Shyangdan D Cummins E Royle P 2011Health Technol Assess2011,15,1:1
4Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic revie- wand meta-analysis 显示文摘SHYANGDAN DS ROYLE PL CLAR C 2010BMC Endocr Disord2010,10,1:1
5Insulin sensitisers in the treat- ment of non-alcoholic fatty liver disease:a systematic review 显示文摘Shyangdan D Clar C Ghouri N 2011Health Technol Assess2011,15,38:1
6Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis显示文摘Shyangdan D S Royle P L Clar C 2010BMC Endocr Disord2010,10,:1
7Glucagon-like peptide analogues for type 2 diabetes mellitus 显示文摘Shyangdan DS Royle P Clar C 2011Cochrane Database Syst Rev2011,10,00:1
8Insulin sensitisers in the treatment of non-alcoholic fatty liver disease:a systematic review显示文摘Shyangdan D Clar C Ghouri N 0,,38:1
9Glucagon- like peptide analogues for type 2 diabetes mellitus 显示文摘Shyangdan DS Royle P Clar C 2011Cochrane Database Syst Rev2011,5,00:1
10A systematic re- view of evidence on malignant spinal metastases: natural histo- ry and teehnologies for identifying patients at high risk of ver- tebral fracture and spinal cord compression显示文摘Sutcliffe P Connoek M Shyangdan D 2013Health Technol Assess2013,17,42:1
11A systematic review of evidence on malignant spinal metastases:natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression显示文摘Sutcliffe P Connock M Shyangdan D 2013Health Technol Assess2013,17,42:1
12Screening for type 2 di-abetes:a short report for the National Screening Committee显示文摘Waugh NR Shyangdan D Taylor-Phillips S 2013Health Tech- nol Assess2013,17,35:1
13Glucagon-like peptide analogues for type 2 diabetes mellitus:systematic review and recta-analysis显示文摘Shyangdan DS Royle PL Clar C 2010BMC Endocr Disord2010,10,:1
14Glucagon-like peptide analogues for type 2 diabetes mell-itus显示文摘SHYANGDAN D S ROYLE P CLAR C 2011Cochrane Database Syst Rev2011,10,00:1
15Liraglutide for the treatment of type 2 diabetes 显示文摘Shyangdan D Cummins E Royle P 2011Health Technol Assess2011,15,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费